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Abstract 
Background: Despite the ever-increasing beneficial applications of 
magnetic nanoparticles in biological systems, few studies have been 
carried out on the combined effects of nanoparticles (Fe and Ni) on 
human health. In the present study the effects of Fe2NiO4 nanoparticle 
on inflammatory factors were assessed.  
Methods: Twenty-four Wistar rats were randomly divided into 3 
groups: two groups were treated with Fe2NiO4 nanoparticle; (2,3) and 
the third group was taken as the control group (1). Group 2 and 3 
received 0.5ml of solution containing 100 and 200 ppm Fe2NiO4 for 7 
successive days, respectively. Inflammatory cytokines such as IL-6 and 
Tumor necrosis factorα (TNFα) were measured at various time points 
(1, 2, 7 and 14 days) by ELISA kits. After 14 days, lung tissue was 
investigated.  
Results: On day 7, IL-6 concentration significantly increased in-
group2. Also during the 14 days, IL-6 concentration significantly 
increased in groups1and2 in comparison with control group. The 
concentration of TNFα on 7th day significantly increased in groups 2 
and 3 and on day 14th, TNFα concentration significantly increased in 
groups 2 and 3compared to control group. There were no pathological 
changes between the control group and group 2 but in-group3, signals 
of fibrous and thickening of the air sacs were observed.  
Conclusion: In the present study we found that inflammatory cytokines 
(IL-6 and TNFα) increased in the groups treated with Fe2NiO4 and 
high dose of this nanoparticles caused drastic changes in lung tissue. 
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Introduction 
In recent years, nanotechnology has led to great changes in the 
industry and in this developing technology the role of nano-materials 
and nano-powders is undeniable. Nanoparticles composed of 
elements such as cobalt-iron and nickel with magnetic properties are 
called "Luxuriate or magneticnanoparticles".1,2 
Magnetic nanoparticles are used for various medical 
conditions.3,4 Typically, the distribution of magnetic 
nanoparticles is varied in different types of organs, for example 
it is 80-90% in the liver, 5-8% in spleen and 1-2% in bone 
marrow. These particles may be interacting to components of 
the extracellular matrix such as plasma membrane of different 
cells including macrophages, endothelial cells, epithelial cells 
of skin and respiratory system (depending on the application 
method and particle size). 
Iron oxide nanoparticles are widely used as a contrast agent 
in nuclear magnetic resonance (MRI) and hyperthermia for 
killing cancer cells. Nickel oxide is also used as catalysts in 
ceramics and storage batteries5 and this particle is a compound 
with very low solubility and high biological resistance in the 
lungs.6 The physiological and chemical properties of nickel 
oxide have made it more useful than any other nanoparticles in 
assessing lung function. Despite the increasing of beneficial 
applications of magnetic nanoparticles in biological systems, 
few studies have been carried out on the combined effects of 
nanoparticles (Fe and Ni) on human health. In the present 
study, the effects of Fe2NiO4 nanoparticle on inflammatory 
factors were assessed. We evaluated the effects of intra-
peritoneal injection of different doses of (100,200 ppm) 
Fe2NiO4 nanoparticles on inflammatory cytokines (TNF, IL-6) 
and lung tissue. 
Methods and Material 
This experimental study was performed on 24Wistar male 
rats. These animals were purchased from the Animal Center of 
the Shahrekord University and housed in stainless steel cages 
in a ventilated animal room. The room temperature was 
maintained at 20±2ºC, with relative humidity (60±10%) and 
12-hour light/dark cycle. 
Distilled water and sterilized food for rats were available ad 
libitum. They were acclimated to this environment for 7 days 
prior to dosing. Animals with a mean weight of 234± 43 g were 
divided into 3 groups: Control (group 1) and treated groups2,3 
received 100 ppm and 200 ppm concentration of Fe2NiO4, 
respectively. Nanoparticle and saline were injected for 7 
consecutive days. 
Nanoparticles of Fe2NiO4 and Fe2NiO4 provided by 
SigmaCo (Germany). In order to make sure of the size 
nanoparticles, 1 g of them was sent to the department of 
Materials Engineering of the Islamic Azad University 
(Najafabad branch), using X-ray tests and confirmed the 
validity of the nanoparticles size (figure 1). 
Concentration of 100 ppm (stock solution 1): 50 mg of 
nanoparticles was required in 1 mL of distilled water (100 
mg/1ml), to achieve 100 ppm concentration of the nanoparticle. 
Concentration of 200 ppm (stock solution 2): 100 mg of 
nanoparticles was required in 2 mL of distilled water 
(200mg/1ml) to achieve 200 ppm concentration of the 
nanoparticle. 
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Detection of according to the manufacturer’s instructions 
(Sigma Co.) at 2nd, 7th and 14th days after treatment 
inflammatory cytokines (IL-6 and TNF-α) were detected in the 
sera using enzyme-linked immunosorbent assay (ELISA) kits. 
All animals (at 14th day) were anesthetized by ether and 
sacrificed for histological assessment. The lung tissue was 
collected for histological evaluation. 
All animal handling and manipulation procedures were 
performed according to the guideline of the Animal Welfare 
Act and Office of Research Ethics Committee of The 
experimental protocol involving animals was approved by the 
Committee of University of Shahrekord  
Histological evaluation was performed according to the 
standard laboratory procedures. A small piece of lung fixed in 
formalin 10% (v/v) was embedded in a paraffin block, sliced 
into 5 μm thicknesses and then placed onto glass slides. The 
section was stained with hematoxylin-eosin (HE) and examined 
by light microscopy. 
Tukey's test was used to evaluate differences between 
groups. P values of less than 0.05 were considered statistically 
significant. 
Results  
Biochemical assessment showed an increased in serum 
levelofIL-6 and TNF-α of mice receiving high dose of 
Fe2NiO4 (200ppm) after 7th and 14th days. 
The level of IL-6 significantly increased in group 3 in 
comparison with group 2 (P= 0.016) and control group1 (P= 
0.030). In the 14th day, IL-6 significantly increased in groups 2 
(P= 0.002) and group 3 (P= 0.007) compared to control group 
(Figure 2). 
Figure 1. X-ray of Fe2NiO4 nanoparticle  
At baseline and the second day, the levels of TNFα were 
similar in three groups )P>0.05(. But on day 7th of the study, 
the level of TNFα increased in group 2 and 3 compared to 
group 1. on day 14th of study, the level of TNFα significantly 
increased in groups 2 and 3 in comparison with control group 
(Figure 3).  
The histological photomicrographs of the liver sections are 
shown in figures 4-6. 
 
Figure 2. Comparison of IL-6(ng/l) concentration between group1, 2 
and 3  
 
Figure 3. Comparison of TNF α (ng/l) concentration between 
group 1, 2 and 3  
 
Figure 4. Light micrographs of lung sections in control group every 
day for 7 successive days (group 1)  
In the control group, there were no pathological changes of 
lung tissue elements such as air bags and there were normal 
blood vessels insight (Figure 4). Although in group 2 there 
were not evident pathological changes in blood vessels but we 
saw slight hyperemia (Figure 5). In group 3, bronchioles were 
normal whereas air sacs wall thickening. Moreover collapse of 
air sacs, increased tissue fibrous and the sign segments was 
seen (Figure 6). 
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F igure 5. Light micrographs of lung sections in Fe2Nio4 -treated rat 
received 100 ppm every day for 7 successive days (group 2) 
 
Figure 6. Light micrographs of lung sections in Fe2Nio4 -treated rat 
received 200 ppm every day for 7 successive days (group 3)  
Discussion 
The results of the present study indicated an increase in 
inflammatory cytokines in the treated groups with Fe2NiO4 
and high dose of this nanoparticles caused drastic changes in 
lung tissue. 
Studies have shown that nanoparticles could cause to 
toxicity includes: Oxidative stress, inflammation, gene damage, 
body harness division and cell death.7-10 Production reactive 
oxygen species (ROS) and oxygen free radicals include 
superoxide an ion radical (O2·-), singlet oxygen (1O2), 
hydroxyl radical (OH) and perhydroxyl radical (HO2·), which 
can be harmful in biological interactions and subsequent 
oxidative stress often have seen in nanoparticles toxicity (11). 
Physicochemical properties such as particle size and 
chemical composition of nanoparticles (NPs) have significant 
impact on tissue damage and ROS production.12 NP-mediated 
ROS responses are accompanied by series of pathological 
events such as genotoxicity, inflammation, fibrosis and 
carcinogenesis. Many nanoparticles activate inflammatory cells 
such as macrophages and neutrophils that lead increased 
production of ROS.13,14,15 
ROS producing mechanism for each nanoparticleis 
different and the exact mechanism for ROS production has not 
yet been fully understood. 
Red ox cycles could activate by many metal nanoparticles 
through reactions that are the most important sources of ROS in 
biological systems such as decomposition of chemical reactions 
and fenton reactions.16,17 
Phagocytes such as neutrophils and macrophages can 
induce oxidative burst after activation as a defense mechanism 
against environmental pollutants, cancer cells and microbes. 
Some nanoparticles such as metal oxide particles can lead to 
ROS production by phagocytes as one of the cytotoxicity 
mechanisms.18 
It has been reported that nanoparticles change the 
intracellular calcium concentration, activate transcription 
factors and cytokine production through production of free 
radicals.19,20 In addition to cellular damage, ROS production 
can be observed during interactions nanoparticle with 
biological targets.21 Significantly, oxidative stresses induced 
by nano-processed materials (NM) can lead to inflammation 
and fibrosis.22-24 
Another possible mechanism is the absorption of chemicals 
such as organic material by the surface of nanoparticles that is 
followed by the induction of inflammatory responses.25 Under 
moderate oxidative stress conditions, pre-inflammatory 
pathways are activated in an attempt to maintain redox balance. 
Inflammatory cascade consists of biochemical events including 
production of inflammatory cytokines such as TNF-α, TGF-β, 
IL-1β which participate in the pathogenesis of fibrosis. 
Cellular response to oxidative stress can operate by 
increasing the production of cytokines (such as interleukin-
1andTNF-α), the activation of kinases and inhibition of 
phosphatases that could affect phosphorylation cascade. Protein 
phosphorylation is involved in theregulation of many critical 
events such as mitogenesis, cell adhesion and apoptosis.26 
The studies27-29 with reference to iron oxide Fe3O4 
(magnetite) have shown that in given equal doses by mass, NPs 
considerably higher cytotoxicity for lung macrophages with 
higher sub-chronic systemic toxicity than micrometric particles 
of the same chemical composition. Moreover, it was indicated 
that, within the established nanometric range, the relationship 
between particle size and toxicity is complicated and non-
unique, which may be due to its distinct properties such as 
differences in the toxicokinetics. This relationship is controlled 
by active physiological mechanisms that are responsible for 
both elimination and retention of NPs with various diameters 
according to their unequal penetrability through biological 
barriers and unequal solubility. 
The results of this study indicated an increase in 
inflammatory cytokines in the rats treated with Fe2NiO4 and 
high dose of these nanoparticles caused drastic changes in lung 
tissue. Although the iron oxide consider as a non-hazardous 
compound but homeostasis imbalance can cause toxic effects. 
Thus, before the application of magnetic nanoparticles, a 
review of toxic and non-essential structures of nanoparticles is 
necessary. 
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